The Library · Peptides
Melanotan II and tanning injections: safety, side effects, and FDA status
The short answer
Melanotan II is an unapproved synthetic peptide sold online as a tanning injection or nasal product. It can darken skin, freckles, and moles, but there is no FDA-approved Melanotan II product, no approved cosmetic-tanning use, and no established consumer dosing or quality standard.
The safety problem is broader than a list of side effects. Long-term human data are limited; products sold outside the regulated drug supply may not reliably contain what the label claims; and injection adds contamination and infection risk. Reports and small studies describe nausea, flushing, appetite changes, fatigue, and spontaneous erections. Published case reports also describe priapism and kidney injury, while dermatology reports describe rapid mole changes. A case report cannot show how often an event happens or prove the peptide caused it, but it is a real safety signal—not evidence of a predictable cosmetic drug.
Do not treat a darker tan as sun protection. If you have used Melanotan II, tell a clinician what product and route you used. Seek urgent care for chest pain, fainting, severe headache or confusion, trouble breathing, severe flank pain or dark urine, or an erection lasting four hours. A new or changing mole needs prompt clinical assessment.
What Melanotan II is—and what it is not
Melanotan II is a lab-made analogue of alpha-melanocyte-stimulating hormone. It activates several melanocortin receptors, including pathways involved in pigment production, appetite, and sexual function. That broad receptor activity helps explain why its effects are not limited to skin color.
Searches often call these products “melanin injections,” but they do not inject the pigment melanin. They attempt to stimulate the body's own pigment response. Melanotan is also unrelated to melatonin, the hormone used in some sleep products.
Melanotan II should not be confused with afamelanotide (Scenesse). The FDA's Drugs@FDA record for Scenesse shows an approved prescription implant for a specific rare light-sensitivity disorder. It is a different medicine, formulation, indication, and clinical setting. Its approval does not validate Melanotan II or cosmetic tanning injections.
FDA status and the “research peptide” label
Melanotan II is not FDA-approved for tanning or any other consumer use. FDA has not reviewed a marketed Melanotan II product for effectiveness, manufacturing quality, sterility, labeling accuracy, or a safe dosing schedule.
“Research use only” is not a safety credential. It does not turn an online vial, pen, or nasal spray into an approved medicine. FDA's rules for bulk substances used in pharmacy compounding also show why “compounded” and “FDA-approved” are not interchangeable terms: compounded products operate under a different legal framework and are not preapproved in the same way as approved drugs.
The regulatory details differ by country, but the central health question is the same: an unapproved product with uncertain identity and quality cannot be assumed safe because it is popular, labeled a peptide, or promoted by a clinic or influencer.
What the evidence actually shows
Early research established that melanocortin analogues can increase pigmentation. That answers the narrow question “can it darken skin?” It does not answer questions about repeated cosmetic use, long-term safety, cancer risk, interactions, or the contents of products now sold online.
A dermatology review indexed by PubMed found that evidence about unregulated melanotan products is dominated by limited studies and case reports. The review highlighted uncertainty about preparation, administration, and product dose, plus reports of changes in existing moles and newly appearing atypical nevi. It also noted melanoma reports but explicitly said a causal link had not been established.
The evidence supports three careful conclusions:
- Melanotan II can stimulate pigmentation.
- Short-term adverse effects and serious case reports exist.
- There is not enough high-quality evidence to call cosmetic use safe or estimate the chance of each harm.
Claims that Melanotan II is a “safer tan” skip a crucial step. Reducing ultraviolet exposure is beneficial, but substituting an unapproved systemic peptide does not make the new exposure safe. A Melanotan tan also does not remove the need for shade, clothing, and sunscreen.
Side effects and safety signals
Small studies, reviews, and adverse-event reports describe nausea, reduced appetite, flushing, facial warmth, headache, fatigue, yawning or sleepiness, darkening of freckles and moles, increased sexual arousal, and spontaneous erections. Reliable frequency estimates are not available for products used outside trials.
Priapism
Melanotan II's sexual effects can become an emergency. A published case report described low-flow priapism after Melanotan use that required emergency treatment. One report does not establish frequency, but an erection lasting four hours can permanently damage erectile tissue and needs emergency care.
Kidney and systemic events
Kidney complications are rare reports, not a proven expected effect. A case report and literature review described renal infarction considered likely related to Melanotan II and discussed earlier reports of rhabdomyolysis and renal failure. These reports cannot prove causation or quantify risk. They do support taking severe flank pain, very dark urine, marked muscle pain or weakness, fainting, or rapidly worsening illness seriously.
Moles and melanoma uncertainty
Melanotan II can darken existing pigmented spots and has been associated in reports with rapidly appearing or changing nevi. That can make skin surveillance more difficult. It has not been proven that Melanotan II causes melanoma, but “not proven” is not the same as “shown to be safe.” Long-term evidence is inadequate.
Use the American Academy of Dermatology's ABCDE warning signs as a prompt to seek an exam, not as a home diagnosis. A spot that is evolving, looks unlike your other moles, bleeds, or changes quickly should be assessed. See Can Melanotan II cause melanoma or change moles?.
Product quality and injection risks
An unregulated product creates additional unknowns: the ingredient or concentration may be wrong; impurities or contamination may be present; sterile manufacturing and storage cannot be assumed; and injection can cause local infection or transmit blood-borne infection when equipment is shared. Nasal products avoid a needle but do not solve identity, purity, absorption, or systemic-safety problems.
This guide does not provide reconstitution, injection, or dosing instructions. There is no approved Melanotan II protocol to make those instructions safe.
What to do if you have already used it
Tell a clinician the product name, when and how it was used, any packaging or ingredient list, and when symptoms began. A clinician can decide whether examination, an ECG, blood or urine testing, or dermatology follow-up is appropriate.
Get urgent help for:
- an erection lasting four hours
- chest pain, fainting, severe shortness of breath, or a severe new headache
- confusion, one-sided weakness, a seizure, or rapidly worsening symptoms
- severe flank pain, very dark urine, or marked muscle pain and weakness
- facial swelling, wheezing, or trouble breathing
- spreading redness, severe pain, pus, or fever after an injection
Arrange prompt assessment for a new or changing mole, especially one that is asymmetric, has an irregular border, develops several colors, bleeds, or is clearly evolving.
Lower-risk ways to get color
Topical sunless-tanning products avoid systemic peptide exposure and injection risk. They still require careful use around the eyes, lips, and inhalation, and usually do not provide meaningful UV protection unless separately labeled with an SPF. Intentional sunbathing and tanning beds add ultraviolet injury and are not a safe workaround.
Compare tanning-injection side effects and safety and how long Melanotan II effects may last. The health guides library covers other evidence-checked questions.
Questions for a doctor or pharmacist
- Do my symptoms after using this product need urgent evaluation or testing?
- Could any medicines or health conditions make these effects more concerning?
- Should a new or changing pigmented spot be examined by a dermatologist?
- If the product was injected, what signs of local or blood-borne infection matter?
- Would a baseline skin examination or photographs help future comparison?
- What lower-risk options fit the cosmetic result I want?
Sources
- FDA Drugs@FDA: Scenesse (afamelanotide), NDA 210797
- FDA: Bulk drug substances used in compounding under section 503A
- PubMed: Risks of unregulated alpha-MSH analogue use—a dermatology review
- PubMed: Melanotan-associated priapism case report
- PubMed: Renal infarction case report and literature review
- American Academy of Dermatology: ABCDEs of melanoma
doc.net is a wellness companion, not medical advice. This guide is general education — see a licensed provider about your specific situation.
More about Melanotan and tanning injections
More in Peptides
Elsewhere in the Library
- Sugar detox — realistic first two weeks →Habits & Lifestyle
- Constipation despite eating fiber →Digestion & Gut
This guide is general — you aren’t.
Get a Blueprint for your specific symptoms, history, and medications — free, no account, in any language.
Begin your consultation